Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 2055357-64-5
2. Jpi-547
3. Jpi547
4. U6n7333gdw
5. Nesuparib [inn]
6. Jpi 547
7. 6-(4-((5-oxo-1,2,3,4,5,6-hexahydrobenzo(h)(1,6)naphthyridin-8-yl)methyl)piperazin-1-yl)nicotinonitrile
8. 6-(4-((5-oxo-1,2,3,4,5,6-hexahydrobenzo[h][1,6]naphthyridin-8-yl)methyl)piperazin-1-yl)nicotinonitrile
9. Refchem:165540
10. Jpi-547 [who-dd]
11. Parp/tnk Inhibitor Jpi-547
12. Nov 1402
13. Parp1/2/tnk1/2 Inhibitor Jpi-547
14. Nov140201
15. Unii-u6n7333gdw
16. Orb1688106
17. Chembl5095245
18. Jpi 547 [who-dd]
19. Schembl18314125
20. Schembl29411324
21. Schembl30093972
22. Glxc-26951
23. Ex-a6172
24. Da-76112
25. Ms-26808
26. Hy-145584
27. Cs-0376456
28. H39853
29. 6-[4-[(1,2,3,4,5,6-hexahydro-5-oxobenzo[h]-1,6-naphthyridin-8-yl)methyl]-1-piperazinyl]-3-pyridinecarbonitrile
| Molecular Weight | 400.5 g/mol |
|---|---|
| Molecular Formula | C23H24N6O |
| XLogP3 | 1.8 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 3 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 84.3 |
| Heavy Atom Count | 30 |
| Formal Charge | 0 |
| Complexity | 733 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
26
PharmaCompass offers a list of Nesuparib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Nesuparib manufacturer or Nesuparib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Nesuparib manufacturer or Nesuparib supplier.
A Nesuparib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Nesuparib, including repackagers and relabelers. The FDA regulates Nesuparib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Nesuparib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Nesuparib supplier is an individual or a company that provides Nesuparib active pharmaceutical ingredient (API) or Nesuparib finished formulations upon request. The Nesuparib suppliers may include Nesuparib API manufacturers, exporters, distributors and traders.
Nesuparib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Nesuparib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Nesuparib GMP manufacturer or Nesuparib GMP API supplier for your needs.
A Nesuparib CoA (Certificate of Analysis) is a formal document that attests to Nesuparib's compliance with Nesuparib specifications and serves as a tool for batch-level quality control.
Nesuparib CoA mostly includes findings from lab analyses of a specific batch. For each Nesuparib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Nesuparib may be tested according to a variety of international standards, such as European Pharmacopoeia (Nesuparib EP), Nesuparib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Nesuparib USP).
